Similar articles

• [Drug binding to blood proteins: characteristics, roles and pathophysiological changes].

  Tillement JP, Duché JC, Barré J. Tillement JP, et al. Bull Acad Natl Med. 2006 Apr-May;190(4-5):935-46; discussion 946-7. Bull Acad Natl Med. 2006. PMID: 17195618 French.
• Binding of drugs to alpha 1-acid glycoprotein and its desialylated form. Influence on hepatic disposition and implications for drug targeting to the liver.

  Meijer DK, van der Sluijs P. Meijer DK, et al. Prog Clin Biol Res. 1989;300:143-67. Prog Clin Biol Res. 1989. PMID: 2674961 Review. No abstract available.
• [Interaction of drugs with alpha 1-acid glycoprotein (orosomucoid)].

  Bender KI, Lutsevich AN. Bender KI, et al. Farmakol Toksikol. 1987 Sep-Oct;50(5):110-9. Farmakol Toksikol. 1987. PMID: 3319686 Review. Russian. No abstract available.
• Elementary pharmacokinetics in clinical practice. 6: Drug concentration monitoring.

  Paxton JW. Paxton JW. N Z Med J. 1982 Mar 10;95(703):150-3. N Z Med J. 1982. PMID: 6952127 No abstract available.
• Pharmacokinetic and pharmacodynamic consequences of altered binding of drugs to alpha 1-acid glycoprotein.

  Belpaire FM, Bogaert MG. Belpaire FM, et al. Prog Clin Biol Res. 1989;300:337-50. Prog Clin Biol Res. 1989. PMID: 2674969 Review. No abstract available.